Donat R Spahn1, Jürg-Hans Beer2, Alain Borgeat3, Pierre-Guy Chassot4, Christian Kern5, François Mach6, Krassen Nedeltchev7, Wolfgang Korte8. 1. Institute of Anesthesiology, University and University Hospital Zurich, Zurich, Switzerland. 2. Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland. 3. Department of Anesthesiology, Balgrist University Hospital, Zurich, Switzerland. 4. Formerly Department of Anesthesiology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland. 5. Department of Anesthesiology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland. 6. Department of Internal Medicine, University Hospitals of Geneva (HUG), Geneva, Switzerland. 7. Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland. 8. Center for Laboratory Medicine; Hemostasis and Hemophilia Center, St. Gallen, Switzerland.
Abstract
BACKGROUND: Due to increasing use of new oral anticoagulants (NOACs), clinicians are faced more and more frequently with clinical issues related to these drugs. OBJECTIVE: The objective of this publication is to make practical suggestions for the perioperative management of NOACs as well as for their handling in overdoses and bleedings. RECOMMENDATIONS: In elective surgery and creatinine clearance ≥ 50 ml/min, a NOAC should be discontinued 24-36 h before the intervention, and even earlier in case of reduced kidney function. In emergency interventions that cannot be delayed, the management is dependent on the NOAC plasma levels. With levels ≤ 30 ng/ml, surgery can be performed. With levels >30 ng/ml, reversal agents should be considered. In low bleeding risk surgery, NOACs can be re-started 24 h after the intervention, which is prolonged to 48-72 h after surgery with high bleeding risk. In case of NOAC overdose and minor bleedings, temporary discontinuation and supportive care are usually sufficient to control the situation. In severe or life-threatening bleedings, nonspecific and specific reversal agents should be considered.
BACKGROUND: Due to increasing use of new oral anticoagulants (NOACs), clinicians are faced more and more frequently with clinical issues related to these drugs. OBJECTIVE: The objective of this publication is to make practical suggestions for the perioperative management of NOACs as well as for their handling in overdoses and bleedings. RECOMMENDATIONS: In elective surgery and creatinine clearance ≥ 50 ml/min, a NOAC should be discontinued 24-36 h before the intervention, and even earlier in case of reduced kidney function. In emergency interventions that cannot be delayed, the management is dependent on the NOAC plasma levels. With levels ≤ 30 ng/ml, surgery can be performed. With levels >30 ng/ml, reversal agents should be considered. In low bleeding risk surgery, NOACs can be re-started 24 h after the intervention, which is prolonged to 48-72 h after surgery with high bleeding risk. In case of NOAC overdose and minor bleedings, temporary discontinuation and supportive care are usually sufficient to control the situation. In severe or life-threatening bleedings, nonspecific and specific reversal agents should be considered.
Authors: Jan Beyer-Westendorf; Kati Förster; Sven Pannach; Franziska Ebertz; Vera Gelbricht; Christoph Thieme; Franziska Michalski; Christina Köhler; Sebastian Werth; Kurtulus Sahin; Luise Tittl; Ulrike Hänsel; Norbert Weiss Journal: Blood Date: 2014-05-23 Impact factor: 22.113
Authors: Pierre Sié; Charles M Samama; Anne Godier; Nadia Rosencher; Annick Steib; Juan V Llau; Philippe Van der Linden; Gilles Pernod; Thomas Lecompte; Isabelle Gouin-Thibault; Pierre Albaladejo Journal: Arch Cardiovasc Dis Date: 2011-10-29 Impact factor: 2.340
Authors: A Hillarp; F Baghaei; I Fagerberg Blixter; K M Gustafsson; L Stigendal; M Sten-Linder; K Strandberg; T L Lindahl Journal: J Thromb Haemost Date: 2011-01 Impact factor: 5.824
Authors: Bradly S Goodman; L McLean House; Sridhar Vallabhaneni; Srinivas Mallempati; Matthew R Willey; Matthew Thomas Smith Journal: Pain Med Date: 2017-07-01 Impact factor: 3.750
Authors: Raquel Ferrandis; Juan V Llau; Javier F Sanz; Concepción M Cassinello; Óscar González-Larrocha; Salomé M Matoses; Vanessa Suárez; Patricia Guilabert; Luís-Miguel Torres; Esperanza Fernández-Bañuls; Consuelo García-Cebrián; Pilar Sierra; Marta Barquero; Nuria Montón; Cristina Martínez-Escribano; Manuel Llácer; Aurelio Gómez-Luque; Julia Martín; Francisco Hidalgo; Gabriel Yanes; Rubén Rodríguez; Beatriz Castaño; Elena Duro; Blanca Tapia; Antoni Pérez; Ángeles M Villanueva; Juan-Carlos Álvarez; Sergi Sabaté Journal: TH Open Date: 2020-06-26